| 1 |
CRISPR-Cas9 base editors and their current role in human therapeutics |
|
| | Walker S. Lahr, Christopher J. Sipe, Joseph G. Skeate, Beau R. Webber, Branden S. Moriarity | | | Cytotherapy. 2023; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Effects of Sirolimus treatment on patients with
ß-Thalassemia
: Lymphocyte immunophenotype and biological activity of memory
CD4
+
and
CD8
+
T cel |
|
| | Matteo Zurlo, Francesco Nicoli, Davide Proietto, Beatrice Dallan, Cristina Zuccato, Lucia Carmela Cosenza, Jessica Gasparello, Chiara Papi, Elisabetta d'Aversa, Monica Borgatti, Chiara Scapoli, Alessia Finotti, Roberto Gambari | | | Journal of Cellular and Molecular Medicine. 2023; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Using Clustered Regularly Interspaced Short Palindromic Repeats gene editing to induce permanent expression of fetal hemoglobin in ß-thalassemia and sickle cell disease: A comparative meta-analysis |
|
| | Anthony Quagliano, Daniel Acevedo, Patrik Hardigan, Samiksha Prasad | | | Frontiers in Medicine. 2022; 9 | | | [Pubmed] [Google Scholar] [DOI] | |
|
